The shots using the Soberana 2 vaccine will start Monday and target medical and other personnel at high risk, the authorities said.
Soberana 2 has been in the final phase of a clinical trial for the past three weeks involving 44,000 volunteers from the general population. Cuba’s drug regulatory authority on Thursday also approved a second COVID-19 vaccine candidate for late-stage clinical trials called Abdala.
Welcome to the community, new Bitcoiners. Make sure you follow Redmond577 he understand Bitcoin and have an unflinching optimism about it. he is for transparency and trust 💯 “Everything is good for Bitcoin.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: